Enric Rello Condomines
Director of Finance/CFO chez ORYZON GENOMICS S.A.
Profil
Enric Rello Condomines is currently the Chief Operating & Financial Officer at Oryzon Genomics SA. He is also a Professor at Universitat Abat Oliba CEU.
Previously, he worked as the Finance Director at Sandoz Industrial Products SA from 1993 to 2007.
Dr. Rello Condomines completed his undergraduate degree at the University of Barcelona and holds undergraduate, graduate, and doctorate degrees from Universitat Abat Oliba CEU.
Postes actifs de Enric Rello Condomines
Sociétés | Poste | Début |
---|---|---|
ORYZON GENOMICS S.A. | Director of Finance/CFO | 01/05/2011 |
Universitat Abat Oliba CEU | Corporate Officer/Principal | - |
Anciens postes connus de Enric Rello Condomines
Sociétés | Poste | Fin |
---|---|---|
Sandoz Industrial Products SA
Sandoz Industrial Products SA Pharmaceuticals: MajorHealth Technology Sandoz Industrial Products SA engages in the manufacture and commercialization of pharmaceutical products. These include generic drugs, anti-infectives, and biosimilars for the treatment of cardiovascular, gastrointestinal, respiratory, and hematological conditions. The company was founded in 1966 and is headquartered in Palafolls, Spain. | Director of Finance/CFO | 01/01/2007 |
Formation de Enric Rello Condomines
University of Barcelona | Undergraduate Degree |
Universitat Abat Oliba CEU | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Entreprise privées | 1 |
---|---|
Sandoz Industrial Products SA
Sandoz Industrial Products SA Pharmaceuticals: MajorHealth Technology Sandoz Industrial Products SA engages in the manufacture and commercialization of pharmaceutical products. These include generic drugs, anti-infectives, and biosimilars for the treatment of cardiovascular, gastrointestinal, respiratory, and hematological conditions. The company was founded in 1966 and is headquartered in Palafolls, Spain. | Health Technology |